Skip to content

Coated VICRYL VCP517HRecalls & reported problems

Ethicon, LLC · Antibacterial Violet Braided (Polyglactin 910), Synthetic Absorbable Suture · Class 2 · Implant

All models of Coated VICRYL (350)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
4
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 10705031054028), received between Apr 8, 2020 and Jun 22, 2026 — classified as 1 injury, 3 malfunctions.

The most frequently reported specific device problem is “Break” (3 reports).

2 other recalls cover devices cleared under the same FDA submission (K032420, K132580, K181652); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 1 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Break3
  • Material Separation1

Patient problems

  • No Clinical Signs, Symptoms or Conditions3
  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJun 22, 2026Break

    IT WAS REPORTED THAT A PATIENT UNDERWENT AN UNKNOWN PROCEDURE ON (B)(6) 2026 AND SUTURE WAS USED. DURING THE PROCEDURE, IT WAS FOUND THAT THE SUTURE WAS BREAKING IN THE PACKAGE. BY THE SUTURE WAS CRACK LIKE A SOLID MATERIAL IN SEVERAL PARTS. THERE WERE NO ADVERSE PATIENT CONSEQUENCES REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 25580209 ↗
  • MalfunctionJan 11, 2022Break; Break

    IT WAS REPORTED THAT A PATIENT UNDERWENT AN OVARIAN CYST REMOVAL ON (B)(6) 2021 AND SUTURE WAS USED. DURING THE PROCEDURE, THE SUTURE BROKE WHILE KNOTTING. CHANGED ANOTHER ONE TO COMPLETE THE SURGERY. NO ADVERSE PATIENT CONSEQUENCES WERE REPORTED. ADDITIONAL INFORMATION WAS REQUESTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 13226574 ↗
  • InjurySep 23, 2021Break; Break

    IT WAS REPORTED THAT THE PATIENT UNDERWENT A C-SECTION ON (B)(6) AND THE SUTURE WAS USED ON THE ADIPOSE LAYER. DURING THE SURGERY, THE NEEDLE WAS BROKEN IN HALF AND BECAME EMBEDDED. X-RAY DETECTED A NEEDLE PIECE. IN ORDER TO FIND THIS MISSING PART OF THE NEEDLE, A SURGEON HAD TO CUT INTO THE LAYER OF SAME FATTY TISSUE. IT WAS REPORTED THAT EVENTUALLY, THE NEEDLE HAD BEEN FOUND DURING SAME PROCEDURE AND DISCARDED. NO NEEDLE LEFT INSIDE OF THE PATIENT. POST-OPERATIVE CARE WAS NOT CHANGED IN ANY WAY AS A RESULT OF THE EVENT. THE PATIENT WAS RE-ASSURED THAT NO NEEDLE LEFT INSIDE OF HER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 12522507 ↗
  • MalfunctionApr 8, 2020Material Separation; Material Separation

    IT WAS REPORTED THAT A PATIENT UNDERWENT A CESAREAN SECTION UNDER EPIDURAL ANESTHESIA ON (B)(6) 2020 AND SUTURE WAS USED. DURING THE PROCEDURE, THE SUTURE PULLED OFF THE NEEDLE WHEN IT WAS SEWING THE UTERUS. CHANGED ANOTHER ONE TO COMPLETE THE SURGERY. THERE WERE NO ADVERSE PATIENT CONSEQUENCES REPORTED. NO ADDITIONAL INFORMATION COULD BE PROVIDED.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 9938163 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K032420, K132580, K181652. One submission often covers many models, so check the product and lot details in each record.

  • Z-2145-2024 · May 10, 2024 · Open, Classified
    VICRYL Plus Antibacterial (polyglactin 910) Suture - Indicated for use in general soft tissue approximation and/or ligation, except for ophthalmic, cardiovascular and neurological
  • Z-1310-2009 · Feb 2, 2009 · Terminated
    Coated VICRYL Plus Antibacterial (polyglactin 910) Suture; Ethicon Inc., A Johnson & Johnson Company, Somerville, NJ Sutures are intended for general soft tissue approximation and

Other SUTURE, ABSORBABLE, SYNTHETIC, POLYGLYCOLIC ACID devices

All SUTURE, ABSORBABLE, SYNTHETIC, POLYGLYCOLIC ACID devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page